Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO) Osimertinib represents the standard of care for the treatment of advanced non-small-cell lung cancer (NSCLC) harboring classical epidermal growth fact…

#ARTICUNO study
📊 largest dataset of #NSCLC with uncommon #EGFR alterations treated with #osimertinib
🧬data on very rare alterations (snv, fusion, KDD), #intracranial activity, and #resistance mechanisms
🔎 #E709 mut->lack of benefit
#LCSM

www.sciencedirect.com/science/arti...